Literature DB >> 18761966

The epidemiology of hepatitis C virus infection in Sweden.

A Duberg1, R Janzon, E Bäck, Karl Ekdahl, A Blaxhult.   

Abstract

In Sweden, infection with hepatitis C virus (HCV) has been a notifiable disease since 1990, when diagnostic methods became available. Blood donor screening indicated that about 0.5% of the Swedish population (9 millions) had been HCV infected. Here we present the Swedish hepatitis C epidemic based on data from all the HCV notifications 1990-2006. During this time about 42,000 individuals (70% men) were diagnosed and reported as HCV infected. The majority (80%) were born in 1950 or later, with a high percentage (60%) born in the 1950s and 1960s. Younger people, 15-24 years old at notification, were reported on the same level each year. The main reported routes of HCV transmission were intravenous drug use in 65%, blood transfusions/products in 6%, and sexual in 2%, though unknown or not stated in 26%. Approximately 6,000 of all notified individuals have died during the study period. To conclude, the Swedish HCV epidemic is highly related to the increase of intravenous drug use in the late 1960s and 1970s, with a high proportion of people now chronically infected for more than 25 years, resulting in an increase of severe liver complications in form of cirrhosis and hepatocellular carcinoma. Furthermore the unchanged number of notifications of newly infected younger people indicates an ongoing HCV epidemic.

Entities:  

Mesh:

Year:  2008        PMID: 18761966     DOI: 10.2807/ese.13.21.18882-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  11 in total

Review 1.  Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.

Authors:  Filippo Ansaldi; Andrea Orsi; Laura Sticchi; Bianca Bruzzone; Giancarlo Icardi
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 2.  Epidemiology and natural history of HCV infection.

Authors:  Behzad Hajarizadeh; Jason Grebely; Gregory J Dore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-02       Impact factor: 46.802

Review 3.  Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent data.

Authors:  Muhammad Umer; Mazhar Iqbal
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

4.  Risk of pancreatic cancer among individuals with hepatitis C or hepatitis B virus infection: a nationwide study in Sweden.

Authors:  J Huang; M Magnusson; A Törner; W Ye; A-S Duberg
Journal:  Br J Cancer       Date:  2013-10-31       Impact factor: 7.640

5.  Molecular characterization of HCV in a Swedish county over 8 years (2002-2009) reveals distinct transmission patterns.

Authors:  Josefine Ederth; Camilla Jern; Helené Norder; Lars Magnius; Erik Alm; Björg Kleverman Rognsvåg; Carl-Gustaf Sundin; Mia Brytting; Joakim Esbjörnsson; Mattias Mild
Journal:  Infect Ecol Epidemiol       Date:  2016-02-05

6.  Cancer risk in patients with hepatitis C virus infection: a population-based study in Sweden.

Authors:  Xiangdong Liu; Yanqing Chen; Youxin Wang; Xiaohua Dong; Junming Wang; Jianhua Tang; Kristina Sundquist; Jan Sundquist; Jianguang Ji
Journal:  Cancer Med       Date:  2017-04-04       Impact factor: 4.452

7.  Prevalence and risk factors for HIV, hepatitis B, and hepatitis C in people with severe mental illness: a total population study of Sweden.

Authors:  Clarissa Bauer-Staeb; Lena Jörgensen; Glyn Lewis; Christina Dalman; David P J Osborn; Joseph F Hayes
Journal:  Lancet Psychiatry       Date:  2017-07-04       Impact factor: 27.083

8.  Initial results of efficacy and safety of Sofosbuvir among Pakistani Population: A real life trial - Hepatitis Eradication Accuracy Trial of Sofosbuvir (HEATS).

Authors:  Zahid Azam; Muhammad Shoaib; Masood Javed; Muhammad Adnan Sarwar; Hafeezullah Shaikh; Nasir Khokhar
Journal:  Pak J Med Sci       Date:  2017 Jan-Feb       Impact factor: 1.088

9.  Hepatitis C prevalence in Denmark -an estimate based on multiple national registers.

Authors:  Peer Brehm Christensen; Gordon Hay; Peter Jepsen; Lars Haukali Omland; Søren Andreas Just; Henrik Bygum Krarup; Nina Weis; Niels Obel; Susan Cowan
Journal:  BMC Infect Dis       Date:  2012-08-06       Impact factor: 3.090

10.  Hepatitis C viremia patterns in incident hepatitis C infection and one year later in 150 prospectively tested persons who inject drugs.

Authors:  Marianne Alanko Blomé; Per Björkman; Vilma Molnegren; Peter Höglund; Anders Widell
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.